Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Alan

Showing results (361-370 of 382) with videos related to

Pageof 39
Sort By:
Pharmacoepidemiology and Drug Safety|February 28, 2024
Staging and clean room: Constructs designed to facilitate transparency and reduce bias in comparative analyses of real-world dataPaul Muntner, Rohini K Hernandez, Shia T Kent, et al.
Journal of the American Society of Nephrology : JASN|February 27, 2016
Epoetin Alfa and Outcomes in Dialysis amid Regulatory and Payment ReformGlenn M Chertow, Jiannong Liu, Keri L Monda, et al.
Pediatrics|July 2, 2023
In-Person Instruction and Educational Outcomes of K-8 Students During the COVID-19 PandemicDiya M Uthappa, Joyce Pak, Kathleen A McGann, et al.
Biorxiv : the Preprint Server for Biology|May 15, 2024
Identification of Fibrinogen as a Plasma Protein Binding Partner for Lecanemab Biosimilar IgG: Implications for Alzheimer's Disease TherapyJean-Pierre Bellier, Andrea Roman, Caitlyn Christiano, et al.
AIDS Patient Care and Stds|November 1, 2017
Underutilization of Statins When Indicated in HIV-Seropositive and Seronegative WomenJonathan V Todd, Stephen R Cole, David A Wohl, et al.
Clinical Pharmacology and Therapeutics|August 20, 2021
Lessons Learned Using Real-World Data to Emulate Randomized Trials: A Case Study of Treatment Effectiveness for Newly Diagnosed Immune ThrombocytopeniaLeah J McGrath, Carrie Nielson, Bradley Saul, et al.
Clinical Pharmacology and Therapeutics|January 14, 2025
Advancing Principled Pharmacoepidemiologic Research to Support Regulatory and Healthcare Decision Making: The Era of Real-World EvidenceRohini K Hernandez, Cathy W Critchlow, Nancy Dreyer, et al.
Advances in Therapy|April 18, 2021
Effectiveness and Safety of Romiplostim Among Patients with Newly Diagnosed, Persistent and Chronic Immune Thrombocytopenia in European Clinical PracticeSara J Snell Taylor, Carrie M Nielson, Alexander Breskin, et al.
Dermatology and Therapy|January 13, 2022
Deucravacitinib in Moderate to Severe Psoriasis: Clinical and Quality-of-Life Outcomes in a Phase 2 TrialDiamant Thaçi, Bruce Strober, Kenneth B Gordon, et al.
Blood|June 9, 2022
Comparative effectiveness of ZUMA-5 (axi-cel) vs SCHOLAR-5 external control in relapsed/refractory follicular lymphomaPaola Ghione, M Lia Palomba, Anik R Patel, et al.
Pageof 39

Showing results (361-370 of 382) with videos related to

Sort By:
Pageof 39
Pharmacoepidemiology and Drug Safety|February 28, 2024
Staging and clean room: Constructs designed to facilitate transparency and reduce bias in comparative analyses of real-world dataPaul Muntner, Rohini K Hernandez, Shia T Kent, et al.
Journal of the American Society of Nephrology : JASN|February 27, 2016
Epoetin Alfa and Outcomes in Dialysis amid Regulatory and Payment ReformGlenn M Chertow, Jiannong Liu, Keri L Monda, et al.
Pediatrics|July 2, 2023
In-Person Instruction and Educational Outcomes of K-8 Students During the COVID-19 PandemicDiya M Uthappa, Joyce Pak, Kathleen A McGann, et al.
Biorxiv : the Preprint Server for Biology|May 15, 2024
Identification of Fibrinogen as a Plasma Protein Binding Partner for Lecanemab Biosimilar IgG: Implications for Alzheimer's Disease TherapyJean-Pierre Bellier, Andrea Roman, Caitlyn Christiano, et al.
AIDS Patient Care and Stds|November 1, 2017
Underutilization of Statins When Indicated in HIV-Seropositive and Seronegative WomenJonathan V Todd, Stephen R Cole, David A Wohl, et al.
Clinical Pharmacology and Therapeutics|August 20, 2021
Lessons Learned Using Real-World Data to Emulate Randomized Trials: A Case Study of Treatment Effectiveness for Newly Diagnosed Immune ThrombocytopeniaLeah J McGrath, Carrie Nielson, Bradley Saul, et al.
Clinical Pharmacology and Therapeutics|January 14, 2025
Advancing Principled Pharmacoepidemiologic Research to Support Regulatory and Healthcare Decision Making: The Era of Real-World EvidenceRohini K Hernandez, Cathy W Critchlow, Nancy Dreyer, et al.
Advances in Therapy|April 18, 2021
Effectiveness and Safety of Romiplostim Among Patients with Newly Diagnosed, Persistent and Chronic Immune Thrombocytopenia in European Clinical PracticeSara J Snell Taylor, Carrie M Nielson, Alexander Breskin, et al.
Dermatology and Therapy|January 13, 2022
Deucravacitinib in Moderate to Severe Psoriasis: Clinical and Quality-of-Life Outcomes in a Phase 2 TrialDiamant Thaçi, Bruce Strober, Kenneth B Gordon, et al.
Blood|June 9, 2022
Comparative effectiveness of ZUMA-5 (axi-cel) vs SCHOLAR-5 external control in relapsed/refractory follicular lymphomaPaola Ghione, M Lia Palomba, Anik R Patel, et al.
Pageof 39